[Sports activity and implantable cardioverter-defibrillator: when is it still possible? A document of the Italian Society of Sports Cardiology (SIC Sport)] [0.03%]
[体育运动与植入型心律转复除颤器：何时仍可行？意大利运动心脏病学会文件]
Alessandro Zorzi,Simone Ungaro,Luigi Sciarra et al.
Alessandro Zorzi et al.
The issue of sports participation in athletes with an implantable cardioverter-defibrillator (ICD) has gained increasing attention. Contrary to what is often reported by the media, in Italy there is no absolute ban on competitive sports for...
Practice Guideline
Giornale italiano di cardiologia (2006). 2026 Mar;27(3):220-230. DOI:10.1714/4650.46652 2026
[Cardiogenetics in Piacenza: integrated care and telemedicine for precision medicine] [0.03%]
[皮亚琴察的心脏遗传学：精确医学的整合护理和远程医疗]
Francesco Di Spigno,Francesca Gualandi,Alessandro Arata et al.
Francesco Di Spigno et al.
Background: Cardiogenetics aims to identify the genetic causes of inherited cardiac diseases, with significant implications for early diagnosis, clinical management, and prevention of sudden cardiac death in both patients...
[Minimally invasive coronary surgery: new developments in myocardial revascularization] [0.03%]
微创冠状动脉手术：心肌血管重建的新进展
Domenico Paparella,Vito Margari,Giuseppe Speziale
Domenico Paparella
Minimally invasive coronary revascularization has gained increasing interest as it represents a significant approach to reducing well-known complications of conventional sternotomy, such as bleeding, need for transfusions, postoperative atr...
Simona Giubilato,Davide Capodanno
Simona Giubilato
Factor XI (FXI) has emerged as a promising target in the prevention and treatment of venous and arterial thromboembolism in several clinical settings. Its pharmacological inhibition, through small molecules, monoclonal antibodies, antisense...
[Non-dilated left ventricular cardiomyopathy: beyond morphology, towards diagnostic precision] [0.03%]
[非扩张型心肌病：超越形态学，迈向精准诊断]
Vanda Parisi,Raffaello Ditaranto,Ferdinando Pasquale et al.
Vanda Parisi et al.
The introduction of non-dilated left ventricular cardiomyopathy (NDLVC) represents one of the key highlights of the 2023 European Society of Cardiology guidelines on cardiomyopathies. NDLVC is defined by the presence of left ventricular sys...
[Transgender individuals and cardiovascular risk: what should the cardiologist know] [0.03%]
心血管风险与变性人：心脏病科医师需要了解什么？
Antonia Mannarini,Maria Teresa Manes,Giuseppe Ciliberti et al.
Antonia Mannarini et al.
Cardiovascular risk estimation in transgender people is an emerging research area with significant clinical implications. Healthcare for transgender people is challenging, as it encompasses the impact of hormone therapies, social inequaliti...
Alessandro Biffi,Fredrick Fernando,Michele Messina et al.
Alessandro Biffi et al.
Cardiovascular diseases remain the leading cause of death and disability in industrialized countries. The workplace represents an ideal setting for primary prevention, allowing for the early identification of individuals at cardiovascular r...
Giampiero Patrizi,Maurizio Casasco,Fabrizio Oliva et al.
Giampiero Patrizi et al.
The benefits of physical exercise are well established and universally recognized, but, at the same time, in our nation we are forced to face extremely annoying data about sedentary habits that directly correlate with the outbreak of many c...
Marco Bernardi,Luigi Spadafora,Laura Adelaide Dalla Vecchia et al.
Marco Bernardi et al.
Artificial intelligence (AI) is rapidly transforming the world, and medicine is at the forefront of this revolution. In cardiology, AI is increasingly providing innovative tools for diagnosis, risk stratification, interventional planning, a...
Lucas Rodrigues Araújo,Horácio Gomes Pereira Filho,Carlos Alberto Pastore
Lucas Rodrigues Araújo